Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Paxmedica Inc (PXMD)

Paxmedica Inc (PXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 747
  • Shares Outstanding, K 7,780
  • Annual Sales, $ 0 K
  • Annual Income, $ -18,290 K
  • 60-Month Beta -0.52
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.49
Trade PXMD with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -9.78
  • Most Recent Earnings $-0.50 on 05/13/24
  • Next Earnings Date 09/18/24 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.30
  • Number of Estimates 1
  • High Estimate -0.30
  • Low Estimate -0.30
  • Prior Year -4.08
  • Growth Rate Est. (year over year) +92.65%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0650 +33.38%
on 09/11/24
0.2560 -66.13%
on 08/21/24
-0.1243 (-58.91%)
since 08/16/24
3-Month
0.0650 +33.38%
on 09/11/24
0.3248 -73.31%
on 07/03/24
-0.1334 (-60.61%)
since 06/18/24
52-Week
0.0650 +33.38%
on 09/11/24
10.2600 -99.15%
on 11/07/23
-5.2054 (-98.36%)
since 09/18/23

Most Recent Stories

More News
PaxMedica Reports First Patient Treated with PAX-101 for Fatal African Sleeping Sickness Infection

Company provides update on regulatory progress towards US NDA submission

PXMD : 0.0867 (-9.69%)
PaxMedica (NASDAQ: PXMD) Developing Treatments for Underserved Neurological Disorders

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company specializing in neurological disorder treatments, is preparing to submit a New Drug Application (“NDA”) to the U.S. Food and Drug Administration...

PXMD : 0.0867 (-9.69%)
PaxMedica (NASDAQ: PXMD) Shares Corporate Update, Commitment to Advancing Therapies for Neurological Disorders

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company specializing in neurological disorder treatments, recently shared corporate updates regarding its continued progress toward establishing suramin as...

PXMD : 0.0867 (-9.69%)
PaxMedica (NASDAQ: PXMD) Seeking to Qualify for Neglected Tropical Disease Priority Review Voucher

PaxMedica (NASDAQ: PXMD), a biopharmaceutical firm dedicated to advancing treatments for neurological disorders, recently announced that it has received an urgent plea from the Ministry of Health (“MOH”)...

PXMD : 0.0867 (-9.69%)
PaxMedica (NASDAQ: PXMD) Dedicated to Ensuring Access to Life-Saving Treatments

PaxMedica (NASDAQ: PXMD), a renowned biopharmaceutical company specializing in treatments for neurological disorders, recently took swift action to address a pressing medical situation unfolding in Malawi,...

PXMD : 0.0867 (-9.69%)
PaxMedica (NASDAQ: PXMD) Announces PAX-101 Batch Completion for NDA Application to FDA

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, recently announced that it has completed its three registration/validation batches of PAX-101,...

PXMD : 0.0867 (-9.69%)
PaxMedica (NASDAQ: PXMD) Featured in Latest Bell2Bell Podcast Release

PaxMedica (NASDAQ: PXMD), a leading biopharmaceutical company dedicated to advancing treatments for neurological disorders, was featured in the latest episode of The Bell2Bell Podcast as part of IBN’s...

PXMD : 0.0867 (-9.69%)
Urgent Action: PaxMedica (NASDAQ: PXMD) Addresses Medical Crisis in Malawi

In recent developments, PaxMedica (NASDAQ: PXMD), a renowned biopharmaceutical company specializing in treatments for neurological disorders, has taken swift action to address a pressing medical situation...

PXMD : 0.0867 (-9.69%)
PaxMedica (NASDAQ: PXMD) Completes Key Step in Preparation of PAX-101 for NDA Submission to FDA

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, has made a key announcement regarding the development of its proprietary PAX-101, an IV...

PXMD : 0.0867 (-9.69%)
PaxMedica (NASDAQ: PXMD) Responding to Emergency Request for IV Suramin from African Health Ministry

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, has received an urgent request from the Ministry of Health (“MOH”) of Malawi requesting...

PXMD : 0.0867 (-9.69%)

Business Summary

PaxMedica Inc., a Phase 2 biotech developing therapies for neurodevelopmental disorders. PaxMedica Inc. is based in Tarrytown, New York.

See More

Key Turning Points

3rd Resistance Point 0.1255
2nd Resistance Point 0.1178
1st Resistance Point 0.1022
Last Price 0.0867
1st Support Level 0.0789
2nd Support Level 0.0712
3rd Support Level 0.0556

See More

52-Week High 10.2600
Fibonacci 61.8% 6.3655
Fibonacci 50% 5.1625
Fibonacci 38.2% 3.9595
Last Price 0.0867
52-Week Low 0.0650

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar